Quality of life findings from a multicenter, multinational, observational study of patients with metastatic hormone-refractory prostate cancer

Patrick W. Sullivan; Parvez M. Mulani; Mayer Fishman; Darryl Sleep

doi:10.1007/s11136-006-9156-2

Quality of life findings from a multicenter, multinational, observational study of patients with metastatic hormone-refractory prostate cancer

Quality of Life Research ◽

10.1007/s11136-006-9156-2 ◽

2007 ◽

Vol 16 (4) ◽

pp. 571-575 ◽

Cited By ~ 47

Author(s):

Patrick W. Sullivan ◽

Parvez M. Mulani ◽

Mayer Fishman ◽

Darryl Sleep

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Observational Study ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Get full-text (via PubEx)

Quality of life findings from a multicenter, multinational, observational study of patients with metatstatic hormone-refractory prostate cancer

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.8106 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 8106-8106 ◽

Cited By ~ 1

Author(s):

M. Fishman ◽

P. Jacobsen ◽

P. Mulani

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Observational Study ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Get full-text (via PubEx)

Baseline quality of life measured with the EORTC QLQ-C30 helps to select a subset of ‘good prognosis’ metastatic hormone refractory prostate cancer patients

European Journal of Cancer ◽

10.1016/s0959-8049(01)81290-9 ◽

2001 ◽

Vol 37 ◽

pp. S218 ◽

Cited By ~ 3

Author(s):

L. Collette ◽

S.D. Fossa ◽

G.O.N. Oosterhof ◽

W. Albrecht ◽

G. van Andel ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Cancer Patients ◽

Good Prognosis ◽

Hormone Refractory Prostate Cancer ◽

Eortc Qlq C30 ◽

Hormone Refractory ◽

Eortc Qlq

Get full-text (via PubEx)

Role of Quality of Life in Men with Metastatic Hormone-Refractory Prostate Cancer: How Does Atrasentan Influence Quality of Life?

European Urology ◽

10.1016/j.eururo.2005.12.058 ◽

2006 ◽

Vol 49 (5) ◽

pp. 781-789 ◽

Cited By ~ 15

Author(s):

David Cella ◽

Daniel P. Petrylak ◽

Mayer Fishman ◽

Chris Teigland ◽

Jay Young ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Get full-text (via PubEx)

Treatment of Hormone-Refractory Prostate Cancer with Docetaxel or Mitoxantrone: Relationships between Prostate-Specific Antigen, Pain, and Quality of Life Response and Survival in the TAX-327 Study

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-07-0944 ◽

2008 ◽

Vol 14 (9) ◽

pp. 2763-2767 ◽

Cited By ~ 149

Author(s):

Dominik R. Berthold ◽

Gregory R. Pond ◽

Martin Roessner ◽

Ronald de Wit ◽

Mario Eisenberger ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Get full-text (via PubEx)

Efficacy of Epoetin Beta on Hemoglobin, Quality of Life, and Transfusion Needs in Patients with Anemia Due to Hormone-refractory Prostate Cancer - A Randomized Study

Scandinavian Journal of Urology and Nephrology ◽

10.1080/003655901750425864 ◽

2001 ◽

Vol 35 (4) ◽

pp. 288-294 ◽

Cited By ~ 47

Author(s):

J-E. Johansson, P. Wersäll, Y. Bran

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Randomized Study ◽

Hormone Refractory Prostate Cancer ◽

Epoetin Beta ◽

Hormone Refractory

Get full-text (via PubEx)

The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: A feasibility study

Annals of Oncology ◽

10.1023/a:1011102619058 ◽

2001 ◽

Vol 12 (5) ◽

pp. 633-641 ◽

Cited By ~ 34

Author(s):

A.B. Kornblith ◽

J.E. Herndon ◽

E. Zuckerman ◽

P.A. Godley ◽

D. Savarese ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Feasibility Study ◽

Low Dose ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory ◽

The Impact

Get full-text (via PubEx)

IMPACT OF DOCETAXEL (D) – BASED CHEMOTHERAPY ON QUALITY OF LIFE (QOL) OF PATIENTS (PTS) WITH HORMONE- REFRACTORY PROSTATE CANCER (HRPC): RESULTS FROM A RANDOMISED PHASE II TRIAL WITH D ± ESTRAMUSTINE (E)

European Urology Supplements ◽

10.1016/s1569-9056(08)60637-5 ◽

2008 ◽

Vol 7 (3) ◽

pp. 231 ◽

Cited By ~ 1

Author(s):

O. Caffo ◽

T. Sava ◽

E. Comploj ◽

Z. Zustovich ◽

R. Segati ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Get full-text (via PubEx)

The Endothelin-1 Antagonist, Atrasentan, Improves Time to Progression and Quality of Life in Hormone-Refractory Prostate Cancer

Clinical Prostate Cancer ◽

10.1016/s1540-0352(11)70127-5 ◽

2002 ◽

Vol 1 (2) ◽

pp. 79-80 ◽

Cited By ~ 4

Author(s):

Maxine Fisher ◽

William K. Oh

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Hormone Refractory Prostate Cancer ◽

Time To Progression ◽

Endothelin 1 ◽

Hormone Refractory

Get full-text (via PubEx)

Oncoxin‑Viusid® may improve quality of life and survival in patients with hormone‑refractory prostate cancer undergoing onco‑specific treatments

Molecular and Clinical Oncology ◽

10.3892/mco.2020.2167 ◽

2020 ◽

Vol 14 (1) ◽

pp. 1-1

Author(s):

Mercedes Fundora Ramos ◽

Lourdes Boulet Maden ◽

Fernando Oriol Casanova ◽

Frank Hernández Cruz ◽

Carina Salgado Reyes ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Hormone Refractory Prostate Cancer ◽

Improve Quality ◽

Hormone Refractory

Get full-text (via PubEx)

Relationship of bone alkaline phosphatase and quality of life in men with hormone refractory prostate cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4688 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4688-4688 ◽

Cited By ~ 1

Author(s):

P. Mulani ◽

D. J. Sleep ◽

J. D. Isaacson ◽

S. M. Hulting ◽

T. Ashraf

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Alkaline Phosphatase ◽

Bone Alkaline Phosphatase ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory ◽

Relationship Of

Get full-text (via PubEx)